SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
268 hedge funds and large institutions have $7.6B invested in Sage Therapeutics in 2018 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 114 increasing their positions, 77 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
5% more call options, than puts
Call options by funds: $61.1M | Put options by funds: $58M
0.51% more ownership
Funds ownership: 103.93% → 104.44% (+0.51%)
1% less capital invested
Capital invested by funds: $7.65B → $7.6B (-$55.9M)
Holders
268
Holding in Top 10
14
Calls
$61.1M
Puts
$58M
Top Buyers
| 1 | +$74.6M | |
| 2 | +$51.2M | |
| 3 | +$38.1M | |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$34.6M |
| 5 |
JPMorgan Chase & Co
New York
|
+$33.1M |
Top Sellers
| 1 | -$154M | |
| 2 | -$44.9M | |
| 3 | -$43.7M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$42.5M |
| 5 |
State Street
Boston,
Massachusetts
|
-$36.9M |